Sorry, but this is bad analysis. There’s a reason pharma stocks tanked when he was appointed. He’s crazy and a lot of his positions (stopping NHI research, gutting FDA, ending user fees) would greatly harm new drug creation/innovation. He’s not aligned to anyone’s interests